Clinical Trial Update: Impact of Maraviroc on the Immune Function in HIV-1 Infected Subjects Receiving Immunisation With Novel Antigens [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of maraviroc on immune responses to novel antigens in HIV-1 infected individuals; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Maraviroc (maraviroc)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV Infections | Phase 4 | Status: TERMINATED